Executive Summary Alcohol misuse and alcohol‐related problems, especially binge drinking and alcohol-related liver disease, are major public health concerns. Recently, much attention has focused on social policy and measures to reduce drinking. There is an additional need to provide care […]
Authors Irene Dunkley, Helen Griffiths, Rachael Follows, Alison Ball, Mandy Collins, Phedra Dodds, Richard Gardner, Victoria Jackson, Claire Rodgers, Barbara Simpson, Nicky Taggart, Tony Tham, Vivienne Wilkin, Andrew Veitch Patients undergoing endoscopy procedures expect support and care from a competent […]
The College’s Datasets for Histopathological Reporting on Cancers have been written to help pathologists work towards a consistent approach for the reporting of the more common cancers and to define the range of acceptable practice in handling pathology specimens.
Dear Liver Section members, I am writing to inform you of a significant caution about the use of ulipristal acetate (Esmya). Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women […]
Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.
Accreditation assessments for services in England, Wales, Northern Ireland and Scotland, including the independent sector are now conducted via https://www.thejag.org.uk
The Report of a Working Party of the British Society of Gastroenterology Endoscopy Committee April 2017 Flexible endoscopes are complex reusable instruments that require unique consideration with respect to decontamination. Their external surfaces and internal channels for air, water, aspiration […]
The MHRA has recently circulated a Drug Safety Update regarding the risk of serious adverse events following the use of intravenous Hyoscine Butylbromide (Buscopan) in patients with underlying cardiac disease. Buscopan is commonly used during endoscopic procedures. It induces smooth […]
An estimated 175,000 people have Lynch syndrome in the UK, however 95% of those do not know they have it. NICE recommends that microsatellite instability (MSI) testing or immunohistochemistry (IHC) should be used on all colorectal cancers, when first diagnosed, […]